A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Epoprostenol
Iproniazid
Iproniazid may increase the hypotensive activities of Temocapril.
Epoprostenol
Clorgiline
Clorgiline may increase the hypotensive activities of Temocapril.
Epoprostenol
Pargyline
Pargyline may increase the hypotensive activities of Temocapril.
Epoprostenol
Rasagiline
Rasagiline may increase the hypotensive activities of Temocapril.
Epoprostenol
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Temocapril.
Epoprostenol
Salvia miltiorrhiza root
Salvia miltiorrhiza root may increase the hypotensive activities of Temocapril.
Epoprostenol
Epoprostenol
Epoprostenol may increase the hypotensive activities of Temocapril.
Epoprostenol
Fostamatinib
Fostamatinib may increase the antihypertensive activities of Temocapril.
Epoprostenol
Mirodenafil
Mirodenafil may increase the antihypertensive activities of Temocapril.
Epoprostenol
Doxofylline
Doxofylline may increase the antihypertensive activities of Temocapril.
Epoprostenol
Udenafil
Udenafil may increase the antihypertensive activities of Temocapril.
Epoprostenol
Avanafil
Avanafil may increase the antihypertensive activities of Temocapril.
Epoprostenol
Ibudilast
Ibudilast may increase the antihypertensive activities of Temocapril.
Epoprostenol
Epitizide
The risk or severity of hypotension can be increased when Epitizide is combined with Temocapril.
Epoprostenol
Quinethazone
The risk or severity of hypotension can be increased when Quinethazone is combined with Temocapril.
Epoprostenol
Loxoprofen
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Loxoprofen is combined with Temocapril.
Epoprostenol
Flurbiprofen axetil
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Flurbiprofen axetil is combined with Temocapril.
Epoprostenol
NS-398
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when NS-398 is combined with Temocapril.
Epoprostenol
SC-236
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when SC-236 is combined with Temocapril.
Epoprostenol
Imidazole salicylate
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Imidazole salicylate is combined with Temocapril.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3